The Necessity and Quandaries of Dengue Vaccine Development
Open Access
- 4 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 203 (3) , 299-303
- https://doi.org/10.1093/infdis/jiq060
Abstract
(See the article by Durbin et al, on pages 327–334 )Keywords
This publication has 94 references indexed in Scilit:
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in HumansScience, 2010
- Report of an NIAID workshop on dengue animal modelsVaccine, 2010
- Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross‐reactiveImmunology & Cell Biology, 2010
- Dengue virus–induced hemorrhage in a nonhuman primate modelBlood, 2010
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeysVaccine, 2010
- A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever ModelPLoS Medicine, 2009
- Targeted Mutagenesis as a Rational Approach to Dengue Virus Vaccine DevelopmentPublished by Springer Nature ,2009
- Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control studyBMC Public Health, 2009
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue VirusJournal of Virology, 2008
- Murine Model for Dengue Virus-Induced Lethal Disease with IncreasedVascular PermeabilityJournal of Virology, 2006